Logo image of BDTX

BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:BDTX - US09203E1055 - Common Stock

2.59 USD
+0.03 (+1.17%)
Last: 1/27/2026, 6:28:46 PM
2.62 USD
+0.03 (+1.16%)
After Hours: 1/27/2026, 6:28:46 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BDTX revenue by date.BDTX revenue by date.
N/AN/A
-100.00%
N/AN/AN/A
224.02%
N/A
233.54%
N/A
139.86%
N/A
63.14%
N/A
35.23%
EBITDA
YoY % growth
BDTX ebitda by date.BDTX ebitda by date.
-4.1M-8.86M
-116.10%
-29.28M
-230.47%
-69.52M
-137.43%
-126.66M
-82.19%
-92.32M
27.11%
-86.023M
6.82%
-78.438M
8.82%
N/A
120.82%
N/A
-459.01%
N/A
-20.09%
N/A
-6.48%
N/A
-16.15%
N/A
58.03%
N/A
246.00%
N/A
158.35%
N/A
54.70%
EBIT
YoY % growth
BDTX ebit by date.BDTX ebit by date.
-4.12M-8.9M
-116.02%
-29.33M
-229.55%
-69.57M
-137.20%
-126.87M
-82.36%
-92.83M
26.83%
-86.46M
6.86%
-78.781M
8.88%
N/A
122.03%
N/A
-415.19%
N/A
-62.58%
N/A
-31.88%
N/A
3.38%
N/A
60.85%
N/A
461.51%
N/A
92.82%
N/A
44.45%
Operating Margin
BDTX operating margin by date.BDTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BDTX eps by date.BDTX eps by date.
N/AN/AN/A-2.05
69.63%
-3.47
-69.22%
-2.52
27.36%
-1.88
25.40%
-1.27
32.45%
N/A
137.63%
N/A
-234.45%
N/A
-55.16%
N/A
20.41%
N/A
28.02%
N/A
92.41%
N/A
2,907.76%
N/A
62.30%
N/A
21.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.19
32.15%
-0.02
-101.93%
-0.21
-8.90%
-0.21
-39.88%
-0.24
-23.94%
-0.17
-815.46%
-0.18
11.27%
-0.19
7.64%
-0.21
9.02%
Revenue
Q2Q % growth

-100.00%
EBITDA
Q2Q % growth
-13.488M
23.63%
-14.307M
-126.20%
-14.521M
-9.62%
-14.266M
-33.09%
-15.683M
-16.27%
-18.727M
-30.89%
-20.043M
-38.02%
-21.471M
-50.50%
-23.042M
-46.93%
EBIT
Q2Q % growth
-13.129M
27.06%
-1.777M
-103.26%
-15.673M
-16.79%
-16.484M
-50.15%
-19.805M
-50.84%
-18.788M
-957.21%
-20.094M
-28.21%
-21.522M
-30.57%
-23.093M
-16.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.15
46.43%
-0.240.0937.31%
Q2 2025
Q2Q % growth
-0.19
47.22%
-0.250.0624.48%
Q1 2025
Q2Q % growth
0.98
380.00%
0.020.964,421.34%
Q4 2024
Q2Q % growth
-0.28
17.65%
-0.320.0412.77%
Q3 2024
Q2Q % growth
-0.28
37.78%
-0.380.1026.57%
Q2 2024
Q2Q % growth
-0.36
30.77%
-0.390.038.83%
Q1 2024
Q2Q % growth
-0.35
38.60%
-0.440.0921.12%
Q4 2023
Q2Q % growth
-0.34
42.37%
-0.480.1428.47%
Q3 2023
Q2Q % growth
-0.45
25.00%
-0.500.059.32%
Q2 2023
Q2Q % growth
-0.52
17.46%
-0.550.034.86%
Q1 2023
Q2Q % growth
-0.57
18.57%
-0.620.058.01%
Q4 2022
Q2Q % growth
-0.59
16.90%
-0.640.057.84%
Q3 2022
Q2Q % growth
-0.60
38.14%
-0.650.058.09%
Q2 2022
Q2Q % growth
-0.63
33.68%
-0.690.069.20%
Q1 2022
Q2Q % growth
-0.70
16.57%
-0.770.078.66%
Q4 2021
Q2Q % growth
-0.71
-12.70%
-1.030.3231.31%
Q3 2021
Q2Q % growth
-0.97
-94.00%
-1.000.032.80%
Q2 2021
Q2Q % growth
-0.95
-131.71%
-0.86-0.09-10.83%
Q1 2021
Q2Q % growth
-0.84
-64.51%
-0.69-0.15-21.29%
Q4 2020
Q2Q % growth
-0.63 -0.640.011.96%
Q3 2020
Q2Q % growth
-0.50 -0.530.036.45%
Q2 2020
Q2Q % growth
-0.41 -0.450.049.47%
Q1 2020
Q2Q % growth
-0.51 -0.49-0.02-3.31%
BDTX Yearly EPS VS EstimatesBDTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
70M 17.85M52.15M292.16%
BDTX Yearly Revenue VS EstimatesBDTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 2.27% 0% 34.84%
RevenueN/A N/A 0% 0%